Department of Surgery, Division of Surgical Oncology, Nagasaki University Hospital, Nagasaki, Japan.
J Surg Res. 2011 Aug;169(2):e119-25. doi: 10.1016/j.jss.2011.04.034. Epub 2011 May 17.
Indocyanine green retention rate at 15 min (ICGR15) is a useful marker of liver function in deciding on the extent of hepatectomy. To determine ICGR15 regardless of liver condition, we sought to establish a formula for converted ICGR15 based on conventional blood tests and technetium-99 m galactosyl human serum albumin ((99m)Tc-GSA) scintigraphy.
We measured liver function parameters, including ICGR15, in 307 patients, including 265 liver cancer patients without biliary obstruction (no obstruction group) and 42 with biliary obstruction (obstruction group).
In the no obstruction group, multiple regression analysis identified blood pool clearance ratio (HH15), liver uptake ratio (LHL15) calculated by heart and liver activity between 3 and 15 min after injection of (99m)Tc-GSA, and serum hyaluronic acid as significant correlates (P < 0.05). The calculated converted ICGR15 was then equal to 0.02∗HA + 0.276∗(HH15∗100)-0.501∗(LHL15∗100) + 41.41. The mean difference between actual and converted ICGR15 was significantly lower in the obstruction than in the no obstruction group (P = 0.031). A significantly larger proportion of patients of the obstruction group had lower converted ICGR15 than those of the no obstruction group (P = 0.045).
The converted ICGR15 is useful for evaluating hepatic function in patients with biliary obstruction who plan to undergo major hepatectomy.
15 分钟吲哚菁绿滞留率(ICGR15)是决定肝切除术范围的肝功能有用标志物。为了确定无论肝脏状况如何的 ICGR15,我们试图建立一个基于常规血液检查和锝-99m 半乳糖基人血清白蛋白((99m)Tc-GSA)闪烁显像的转换 ICGR15 公式。
我们测量了 307 例患者的肝功能参数,包括 ICGR15,其中 265 例为无胆道梗阻的肝癌患者(无梗阻组),42 例为有胆道梗阻的患者(梗阻组)。
在无梗阻组中,多元回归分析确定了血池清除率(HH15)、注射(99m)Tc-GSA 后 3 至 15 分钟内心脏和肝脏活动之间计算的肝脏摄取率(LHL15)以及血清透明质酸为显著相关因素(P <0.05)。然后计算的转换后的 ICGR15 等于 0.02∗HA + 0.276∗(HH15∗100)-0.501∗(LHL15∗100)+41.41。梗阻组的实际和转换后的 ICGR15 之间的平均差异明显低于无梗阻组(P=0.031)。梗阻组中转换后的 ICGR15 较低的患者比例明显高于无梗阻组(P=0.045)。
对于计划接受大肝切除术的胆道梗阻患者,转换后的 ICGR15 可用于评估肝功能。